Bristlecone Advisors’s Tvardi Therapeutics, Inc. Common Stock TVRD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2017
Q4
Sell
-30
Closed -$15K 266
2017
Q3
$15K Buy
+30
New +$15K ﹤0.01% 253